Novostia on LinkedIn: Press Release - Sept.2024 | 22 comments
Summary
\U0001f31f\U0001f389 We are thrilled to announce the successful implantation of our 10th patient with the TRIFLO Heart Valve in our First-In-Human clinical study! This marks the completion of all planned implantations in the PILATUS study (https://lnkd.in/eAD28T5Z). From December 2023 to May 2024, our surgical teams delivered outstanding results, with patients showing remarkable recovery. The TRIFLO Heart Valve aims to eliminate lifelong anticoagulation therapy, improving patient quality of life.\U0001fac0 Special thanks to Prof. Kstutis Ruinskas and his team at Vilnius University Hospital Santaros Klinikos for their exceptional leadership. Stay tuned for more updates as we continue to transform aortic valve treatment!
Funding
Amount
$6.6M
Total raised
Date
September 9, 2024
Announcement date
Investors
-
Lead investors
Company
https://www.novostia.com/
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected
Linked Companies
Refresh Inc.
$1M to $5M